For: | Deng JY, Sun D, Liu XY, Pan Y, Liang H. STAT-3 correlates with lymph node metastasis and cell survival in gastric cancer. World J Gastroenterol 2010; 16(42): 5380-5387 [PMID: 21072904 DOI: 10.3748/wjg.v16.i42.5380] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v16/i42/5380.htm |
Number | Citing Articles |
1 |
Qing Zhu, Feng Gu, Caixia Zhu, Yuyan Wang, Fang Wei, Qiliang Cai. Infectious Agents Associated Cancers: Epidemiology and Molecular Biology. Advances in Experimental Medicine and Biology 2017; 1018: 253 doi: 10.1007/978-981-10-5765-6_16
|
2 |
Hazel Tye, Brendan J. Jenkins. Tying the knot between cytokine and toll‐like receptor signaling in gastrointestinal tract cancers. Cancer Science 2013; 104(9): 1139 doi: 10.1111/cas.12205
|
3 |
Petra Hudler. Genetic Aspects of Gastric Cancer Instability. The Scientific World Journal 2012; 2012: 1 doi: 10.1100/2012/761909
|
4 |
Lidia Avalle, Gabriella Regis, Valeria Poli. Jak-Stat Signaling : From Basics to Disease. 2012; : 305 doi: 10.1007/978-3-7091-0891-8_17
|
5 |
PUJA KHANNA, PEI JOU CHUA, BOON HUAT BAY, GYEONG HUN BAEG. The JAK/STAT signaling cascade in gastric carcinoma (Review). International Journal of Oncology 2015; 47(5): 1617 doi: 10.3892/ijo.2015.3160
|
6 |
Zhe-Wei Wei, Guang-Kai Xia, Ying Wu, Wei Chen, Zhen Xiang, Roderich E. Schwarz, Rolf A. Brekken, Niranjan Awasthi, Yu-Long He, Chang-Hua Zhang. CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer. Cancer Letters 2015; 359(2): 335 doi: 10.1016/j.canlet.2015.01.033
|
7 |
Minmin Xu, Li Ren, Jinhua Fan, Lu Huang, Liming Zhou, Xuegang Li, Xiaoli Ye. Berberine inhibits gastric cancer development and progression by regulating the JAK2/STAT3 pathway and downregulating IL-6. Life Sciences 2022; 290: 120266 doi: 10.1016/j.lfs.2021.120266
|
8 |
Yong Liu, Jingyu Deng, Xuegang Luo, Yuan Pan, Li Zhang, Rupeng Zhang, Han Liang. Overexpression of SMYD3 was associated with increased STAT3 activation in gastric cancer. Medical Oncology 2015; 32(1) doi: 10.1007/s12032-014-0404-y
|
9 |
Ha‐Na Oh, Ji‐Hye Seo, Mee‐Hyun Lee, Cheolhee Kim, Eunae Kim, Goo Yoon, Seung‐Sik Cho, Young Sik Cho, Hyun Woo Choi, Jung‐Hyun Shim, Jung‐Il Chae. Licochalcone C induced apoptosis in human oral squamous cell carcinoma cells by regulation of the JAK2/STAT3 signaling pathway. Journal of Cellular Biochemistry 2018; 119(12): 10118 doi: 10.1002/jcb.27349
|
10 |
Kun Ji, Liyan Zhang, Mingxuan Zhang, Qi Chu, Xin Li, Wei Wang. Prognostic Value and Clinicopathological Significance of p-stat3 Among Gastric Carcinoma Patients. Medicine 2016; 95(5): e2641 doi: 10.1097/MD.0000000000002641
|
11 |
WEN-YONG WU, JUN LI, ZHENG-SHENG WU, CHANG-LE ZHANG, XIANG-LING MENG, PETER E. LOBIE. Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in hepatocellular carcinoma. Experimental and Therapeutic Medicine 2011; 2(4): 647 doi: 10.3892/etm.2011.254
|
12 |
Daniel V.T. Catenacci, Gustavo Cervantes, Soheil Yala, Erik A. Nelson, Essam El-Hashani, Rajani Kanteti, Mohamed El Dinali, Rifat Hasina, Johannes Brägelmann, Tanguy Seiwert, Michele Sanicola, Les Henderson, Tatyana A. Grushko, Olufunmilayo Olopade, Theodore Karrison, Yung-Jue Bang, Woo Ho Kim, Maria Tretiakova, Everett Vokes, David A. Frank, Hedy L. Kindler, Heather Huet, Ravi Salgia. RON(MST1R)is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma. Cancer Biology & Therapy 2011; 12(1): 9 doi: 10.4161/cbt.12.1.15747
|
13 |
Kishore Kumar Jella. Role of Transcription Factors in Gastrointestinal Malignancies. 2017; : 161 doi: 10.1007/978-981-10-6728-0_11
|
14 |
Andrew S Giraud, Trevelyan R Menheniott, Louise M Judd. Targeting STAT3 in gastric cancer. Expert Opinion on Therapeutic Targets 2012; 16(9): 889 doi: 10.1517/14728222.2012.709238
|
15 |
Zheng-Sheng Wu, Xing-Wang Cheng, Xiao-Nan Wang, Ning-Jing Song. Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in human cutaneous melanoma. Melanoma Research 2011; 21(6): 483 doi: 10.1097/CMR.0b013e32834acc37
|
16 |
Yuan-Fei Liu, Yun-Min Lu, Guo-Qiang Qu, Yuan Liu, Wei-Xiong Chen, Xiao-Hong Liao, Wu-Ming Kong. Ponicidin Induces Apoptosis via JAK2 and STAT3 Signaling Pathways in Gastric Carcinoma. International Journal of Molecular Sciences 2015; 16(1): 1576 doi: 10.3390/ijms16011576
|
17 |
Catherine Cafferkey, Ian Chau. Novel STAT 3 inhibitors for treating gastric cancer. Expert Opinion on Investigational Drugs 2016; 25(9): 1023 doi: 10.1080/13543784.2016.1195807
|
18 |
Aneta Słabuszewska-Jóźwiak, Aron Lukaszuk, Marta Janicka-Kośnik, Artur Wdowiak, Grzegorz Jakiel. Role of Leptin and Adiponectin in Endometrial Cancer. International Journal of Molecular Sciences 2022; 23(10): 5307 doi: 10.3390/ijms23105307
|
19 |
Ashleigh R. Poh, Amy R. Dwyer, Moritz F. Eissmann, Ashwini L. Chand, David Baloyan, Louis Boon, Michael W. Murrey, Lachlan Whitehead, Megan O'Brien, Clifford A. Lowell, Tracy L. Putoczki, Fiona J. Pixley, Robert J.J. O'Donoghue, Matthias Ernst. Inhibition of the SRC Kinase HCK Impairs STAT3-Dependent Gastric Tumor Growth in Mice. Cancer Immunology Research 2020; 8(4): 428 doi: 10.1158/2326-6066.CIR-19-0623
|
20 |
Anne Huber, Amr H. Allam, Christine Dijkstra, Stefan Thiem, Jennifer Huynh, Ashleigh R. Poh, Joshua Konecnik, Saumya P. Jacob, Rita Busuttil, Yang Liao, David Chisanga, Wei Shi, Mariah G. Alorro, Stephen Forrow, Daniele V.F. Tauriello, Eduard Batlle, Alex Boussioutas, David S. Williams, Michael Buchert, Matthias Ernst, Moritz F. Eissmann. Mutant TP53 switches therapeutic vulnerability during gastric cancer progression within interleukin-6 family cytokines. Cell Reports 2024; 43(8): 114616 doi: 10.1016/j.celrep.2024.114616
|
21 |
Pin Wu, Dang Wu, Lufeng Zhao, Lijian Huang, Gang Shen, Jian Huang, Ying Chai. Prognostic role of STAT3 in solid tumors: a systematic review and meta-analysis. Oncotarget 2016; 7(15): 19863 doi: 10.18632/oncotarget.7887
|
22 |
Benjamin J. Bernard, Nupur Nigam, Kyunghee Burkitt, Vassiliki Saloura. SMYD3: a regulator of epigenetic and signaling pathways in cancer. Clinical Epigenetics 2021; 13(1) doi: 10.1186/s13148-021-01021-9
|
23 |
Pei Jou Chua, Jia Pei Lim, Tian Tian Guo, Puja Khanna, Qidong Hu, Boon Huat Bay, Gyeong Hun Baeg. Y-box binding protein-1 and STAT3 independently regulate ATP-binding cassette transporters in the chemoresistance of gastric cancer cells. International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4557
|
24 |
Janson Tse, Thomas Pierce, Annalisa L. E. Carli, Mariah G. Alorro, Stefan Thiem, Eric G. Marcusson, Matthias Ernst, Michael Buchert. Onco-miR-21 Promotes Stat3-Dependent Gastric Cancer Progression. Cancers 2022; 14(2): 264 doi: 10.3390/cancers14020264
|
25 |
Ji Di, Bo Jiang, Hao Shang, Xin Yang, Chengwu Zhang, Xiali Shi, Yan Chai, Mohammad Farukh Hashmi. [Retracted] Study on the Mechanism of Action of STAT3 in the Drug Resistance of Gastric Cancer Cells. Contrast Media & Molecular Imaging 2022; 2022(1) doi: 10.1155/2022/1426343
|
26 |
Jingyu Deng, Han Liang, Rupeng Zhang, Dan Sun, Yi Pan, Yong Liu, Li Zhang, Xishan Hao. STAT3 is associated with lymph node metastasis in gastric cancer. Tumor Biology 2013; 34(5): 2791 doi: 10.1007/s13277-013-0837-5
|
27 |
Mu-xing Li, Xin-yu Bi, Zhen Huang, Jian-jun Zhao, Yue Han, Zhi-yu Li, Ye-fan Zhang, Yuan Li, Xiao Chen, Xu-hui Hu, Hong Zhao, Jian-qiang Cai, Elda Tagliabue. Prognostic Role of Phospho-STAT3 in Patients with Cancers of the Digestive System: A Systematic Review and Meta-Analysis. PLOS ONE 2015; 10(5): e0127356 doi: 10.1371/journal.pone.0127356
|
28 |
Pranabananda Dutta, Willis X Li. Encyclopedia of Life Sciences. 2013; doi: 10.1002/9780470015902.a0025214
|
29 |
Yujie Zhang, Chaoran Yu. Prognostic values of signal transducers activators of transcription in gastric cancer. Bioscience Reports 2019; 39(4) doi: 10.1042/BSR20181695
|
30 |
Moon Kyung Joo, Jong-Jae Park, Hoon Jai Chun. Proton pump inhibitor: The dual role in gastric cancer. World Journal of Gastroenterology 2019; 25(17): 2058-2070 doi: 10.3748/wjg.v25.i17.2058
|
31 |
MAREIKE SEELINGER, RUXANDRA POPESCU, BENEDIKT GIESSRIGL, KANOKWAN JARUKAMJORN, CHRISTINE UNGER, BRUNO WALLNÖFER, MONIKA FRITZER-SZEKERES, THOMAS SZEKERES, RENE DIAZ, WALTER JÄGER, RICHARD FRISCH, BRIGITTE KOPP, GEORG KRUPITZA. Methanol extract of the ethnopharmaceutical remedy Smilax spinosa exhibits anti-neoplastic activity. International Journal of Oncology 2012; 41(3): 1164 doi: 10.3892/ijo.2012.1538
|
32 |
Shuyan Luo, Shaonan Du, Mei Tao, Jingyuan Cao, Peng Cheng. Insights on hematopoietic cell kinase: An oncogenic player in human cancer. Biomedicine & Pharmacotherapy 2023; 160: 114339 doi: 10.1016/j.biopha.2023.114339
|
33 |
Do-Youn Oh, Se-Hoon Lee, Sae-Won Han, Mi-Jung Kim, Tae-Min Kim, Tae-You Kim, Dae Seog Heo, Miyuki Yuasa, Yasuo Yanagihara, Yung-Jue Bang. Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors. Cancer Research and Treatment 2015; 47(4): 607 doi: 10.4143/crt.2014.249
|
34 |
Mohammed Samsuzzaman, Byeong-Churl Jang. Growth-Suppressive and Apoptosis-Inducing Effects of Tetrandrine in SW872 Human Malignant Liposarcoma Cells via Activation of Caspase-9, Down-Regulation of XIAP and STAT-3, and ER Stress. Biomolecules 2022; 12(6): 843 doi: 10.3390/biom12060843
|
35 |
Miguel S. Gonzalez-Mancera, Britt Johnson, Mehdi Mirsaeidi. STAT3 gain-of-function mutation in a patient with pulmonary Mycobacterium abscessus infection. Respiratory Medicine Case Reports 2020; 30: 101125 doi: 10.1016/j.rmcr.2020.101125
|
36 |
Natasha Costa da Rocha Galucio, Daniele de Araújo Moysés, Jeferson Rodrigo Souza Pina, Patrícia Santana Barbosa Marinho, Paulo Cardoso Gomes Júnior, Jorddy Neves Cruz, Valdicley Vieira Vale, André Salim Khayat, Andrey Moacir do Rosario Marinho. Antiproliferative, genotoxic activities and quantification of extracts and cucurbitacin B obtained from Luffa operculata (L.) Cogn. Arabian Journal of Chemistry 2022; 15(2): 103589 doi: 10.1016/j.arabjc.2021.103589
|
37 |
Yile Liao, Yu Gui, Qingzhou Li, Jun An, Dong Wang. The signaling pathways and targets of natural products from traditional Chinese medicine treating gastric cancer provide new candidate therapeutic strategies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2023; 1878(6): 188998 doi: 10.1016/j.bbcan.2023.188998
|
38 |
Puja Kachroo, Mi-Heon Lee, Ling Zhang, Felicita Baratelli, Gina Lee, Minu K Srivastava, Gerald Wang, Tonya C Walser, Kostyantyn Krysan, Sherven Sharma, Steven M Dubinett, Jay M Lee. IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer. Journal of Experimental & Clinical Cancer Research 2013; 32(1) doi: 10.1186/1756-9966-32-97
|
39 |
Yong Teng, James L Ross, John K Cowell. The involvement of JAK-STAT3 in cell motility, invasion, and metastasis. JAK-STAT 2014; 3(1): e28086 doi: 10.4161/jkst.28086
|
40 |
HONG-WEI XU, FENG REN, YAN-MING YU, CHENG-ZHONG CAI. Runx3 expression in lymph nodes with metastasis is associated with the outcome of gastric cancer patients. Oncology Letters 2011; 2(6): 1275 doi: 10.3892/ol.2011.381
|
41 |
Toshiya Sakamoto, Satoshi Kuboki, Katsunori Furukawa, Tsukasa Takayashiki, Shigetsugu Takano, Arihito Yoshizumi, Masayuki Ohtsuka. TRIM27‐USP7 complex promotes tumour progression via STAT3 activation in human hepatocellular carcinoma. Liver International 2023; 43(1): 194 doi: 10.1111/liv.15346
|
42 |
Sung Yeul Yang, Thi Thinh Nguyen, Trong Thuan Ung, Young Do Jung. Role of Recepteur D'origine Nantais on Gastric Cancer Development and Progression. Chonnam Medical Journal 2017; 53(3): 178 doi: 10.4068/cmj.2017.53.3.178
|
43 |
Diana Pádua, Paula Figueira, Inês Ribeiro, Raquel Almeida, Patrícia Mesquita. The Relevance of Transcription Factors in Gastric and Colorectal Cancer Stem Cells Identification and Eradication. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00442
|
44 |
Mayra Suelen da S. Pinheiro, Daniele A. Moysés, Natasha C. R. Galucio, Willian Oliveira Santos, Jeferson R. Souza Pina, Luana C. Oliveira, Simone Yasue S. Silva, Sebastião da Cruz Silva, Nilton Ferreira Frazão, Patrícia Santana B. Marinho, Andrea L. F. Novais, André S. Khayat, Andrey Moacir do Rosário Marinho.
Cytotoxic and molecular evaluation of spilanthol obtained from
Acmella oleracea
(L.) R. K. Jansen (jambu) in human gastric cancer cells
. Natural Product Research 2024; 38(10): 1806 doi: 10.1080/14786419.2023.2222220
|
45 |
Weifeng Zhang, Minghui Wan, Lunchao Ma, Xiang Liu, Jianxing He. Protective effects of ADAM8 against cisplatin‐mediated apoptosis in non‐small‐cell lung cancer. Cell Biology International 2013; 37(1): 47 doi: 10.1002/cbin.10011
|
46 |
Eva Van Overmeire, Damya Laoui, Jiri Keirsse, Jo A. Van Ginderachter, Adelaida Sarukhan. Mechanisms Driving Macrophage Diversity and Specialization in Distinct Tumor Microenvironments and Parallelisms with Other Tissues. Frontiers in Immunology 2014; 5 doi: 10.3389/fimmu.2014.00127
|
47 |
Yonggang Tian, Yunqian Xie, Guirong Yi, Fanqi Wu, Xiaoyu Dang, Feihu Bai, Jun Wang, Dekui Zhang. Prognostic Value and Therapeutic Significance of CCL Chemokines in Gastric Cancer. Current Medicinal Chemistry 2024; 31(42): 7043 doi: 10.2174/0109298673315146240731100101
|
48 |
Adria Hasan, Naushad Ahmad Khan, Shahab Uddin, Abdul Q. Khan, Martin Steinhoff. Deregulated transcription factors in the emerging cancer hallmarks. Seminars in Cancer Biology 2024; 98: 31 doi: 10.1016/j.semcancer.2023.12.001
|
49 |
Yan-Shen Shan, Hui-Ping Hsu, Ming-Derg Lai, Meng-Chi Yen, Wei-Ching Chen, Jung-Hua Fang, Tzu-Yang Weng, Yi-Ling Chen. Argininosuccinate synthetase 1 suppression and arginine restriction inhibit cell migration in gastric cancer cell lines. Scientific Reports 2015; 5(1) doi: 10.1038/srep09783
|
50 |
Jagat R. Kanwar, Sishir K. Kamalapuram, Rupinder K. Kanwar. Survivin Signaling in Clinical Oncology: A Multifaceted Dragon. Medicinal Research Reviews 2013; 33(4): 765 doi: 10.1002/med.21264
|
51 |
JUNMIN SONG, HONGXIANG LIU, ZHEN LI, CHAO YANG, CHAOJIE WANG. Cucurbitacin I inhibits cell migration and invasion and enhances chemosensitivity in colon cancer. Oncology Reports 2015; 33(4): 1867 doi: 10.3892/or.2015.3749
|
52 |
Jingyu Deng, Xuguang Jiao, Honggen Liu, Liangliang Wu, Rupeng Zhang, Baogui Wang, Yi Pan, Xishan Hao, Han Liang. Lymph node metastasis is mediated by suppressor of cytokine signaling-3 in gastric cancer. Tumor Biology 2013; 34(6): 3627 doi: 10.1007/s13277-013-0944-3
|
53 |
S. Yu, G. Li, Z. Wang, Z. Wang, C. Chen, S. Cai, Y. He. The prognostic value of pSTAT3 in gastric cancer: a meta-analysis. Journal of Cancer Research and Clinical Oncology 2016; 142(3): 649 doi: 10.1007/s00432-015-2023-1
|
54 |
Jin Long Liu, Wei Gao, Qing Min Kang, Xue Jun Zhang, Shu Guang Yang, Hiromu Suzuki. Prognostic Value of Survivin in Patients with Gastric Cancer: A Systematic Review with Meta-Analysis. PLoS ONE 2013; 8(8): e71930 doi: 10.1371/journal.pone.0071930
|
55 |
Gayathri Anandappa, Ian Chau. Emerging Novel Therapeutic Agents in the Treatment of Patients with Gastroesophageal and Gastric Adenocarcinoma. Hematology/Oncology Clinics of North America 2017; 31(3): 529 doi: 10.1016/j.hoc.2017.02.001
|
56 |
Cendy A. Valle Oseguera, Juliet V. Spencer, Nancy M. Sawtell. cmvIL-10 Stimulates the Invasive Potential of MDA-MB-231 Breast Cancer Cells. PLoS ONE 2014; 9(2): e88708 doi: 10.1371/journal.pone.0088708
|
57 |
Miran Jo, Mi Hee Park, Pushpa Saranya Kollipara, Byeong Jun An, Ho Sueb Song, Sang Bae Han, Jang Heub Kim, Min Jong Song, Jin Tae Hong. Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway. Toxicology and Applied Pharmacology 2012; 258(1): 72 doi: 10.1016/j.taap.2011.10.009
|
58 |
Min Wu, Yan Wu, Ting Lan, Lu Jiang, Hai Qian, Yongchang Chen. Type II cGMP-dependent protein kinase inhibits EGF-induced JAK/STAT signaling in gastric cancer cells. Molecular Medicine Reports 2016; 14(2): 1849 doi: 10.3892/mmr.2016.5452
|
59 |
Shun Li, Ni Wang, Pnina Brodt. Metastatic Cells Can Escape the Proapoptotic Effects of TNF-α through Increased Autocrine IL-6/STAT3 Signaling. Cancer Research 2012; 72(4): 865 doi: 10.1158/0008-5472.CAN-11-1357
|
60 |
María Claudia Sandoval-Usme, Adriana Umaña-Pérez, Borja Guerra, Orlando Hernández-Perera, José Manuel García-Castellano, Leandro Fernández-Pérez, Myriam Sánchez-Gómez, Chih-Hsin Tang. Simvastatin Impairs Growth Hormone-Activated Signal Transducer and Activator of Transcription (STAT) Signaling Pathway in UMR-106 Osteosarcoma Cells. PLoS ONE 2014; 9(1): e87769 doi: 10.1371/journal.pone.0087769
|
61 |
Zizhen Wu, Huifang Liu, Weilin Sun, Yingxin Du, Wenting He, Shiwei Guo, Liqiao Chen, Zhenzhen Zhao, Pengliang Wang, Han Liang, Jingyu Deng. RNF180 mediates STAT3 activity by regulating the expression of RhoC via the proteasomal pathway in gastric cancer cells. Cell Death & Disease 2020; 11(10) doi: 10.1038/s41419-020-03096-3
|
62 |
XIAOCHUN WANG, PHILIP J. CROWE, DAVID GOLDSTEIN, JIA-LIN YANG. STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers. International Journal of Oncology 2012; 41(4): 1181 doi: 10.3892/ijo.2012.1568
|
63 |
An-Quan Shang, Jian Wu, Feng Bi, Yu-Jie Zhang, Lei-Rong Xu, Ling-Ling Li, Fei-Fei Chen, Wei-Wei Wang, Jian-Jun Zhu, You-Yi Liu. Relationship between HER2 and JAK/STAT-SOCS3 signaling pathway and clinicopathological features and prognosis of ovarian cancer. Cancer Biology & Therapy 2017; 18(5): 314 doi: 10.1080/15384047.2017.1310343
|
64 |
Archana Chaudhary, Syed Shadab Raza, Rizwanul Haque. Transcriptional factors targeting in cancer stem cells for tumor modulation. Seminars in Cancer Biology 2023; 88: 123 doi: 10.1016/j.semcancer.2022.12.010
|
65 |
Ruihong Zhao, Zhangmin Hu, Xiaoli Zhang, Shujuan Huang, Guodong Yu, Zhe Wu, Wei Yu, Juan Lu, Bing Ruan. The oncogenic mechanisms of the Janus kinase-signal transducer and activator of transcription pathway in digestive tract tumors. Cell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-023-01421-9
|
66 |
Arvind Pandey, Satyendra Chandra Tripathi, Shirish Shukla, Sutapa Mahata, Kanchan Vishnoi, Sri Prakash Misra, Vatsala Misra, Sankar Mitra, Manisha Dwivedi, Alok C. Bharti. Differentially localized survivin and STAT3 as markers of gastric cancer progression: Association with Helicobacter pylori. Cancer Reports 2018; 1(1) doi: 10.1002/cnr2.1004
|
67 |
Mahdi Abdoli Shadbad, Khalil Hajiasgharzadeh, Behzad Baradaran. Cross-talk between myeloid-derived suppressor cells and Mucin1 in breast cancer vaccination: On the verge of a breakthrough. Life Sciences 2020; 258: 118128 doi: 10.1016/j.lfs.2020.118128
|
68 |
Fuli Gao, Ying Lv, Yinxin Zhu, Min Chen, Shanshan Shen, Jun Cao, Xiaoping Zou. Correlation of Epigenetic Aberrance with STAT3 Signaling Pathway in Gastric Carcinogenesis. Digestive Diseases and Sciences 2012; 57(8): 2055 doi: 10.1007/s10620-012-2152-1
|
69 |
Xiaoxia Jiang, Jian Tang, Mengjie Wu, Shitu Chen, Zhenzhen Xu, Haiyong Wang, Haohao Wang, Xiongfei Yu, Zhongqi Li, Lisong Teng. BP‑1‑102 exerts an antitumor effect on the AGS human gastric cancer cell line through modulating the STAT3 and MAPK signaling pathways. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.9892
|
70 |
Tracy L. Putoczki, Stefan Thiem, Andrea Loving, Rita A. Busuttil, Nicholas J. Wilson, Paul K. Ziegler, Paul M. Nguyen, Adele Preaudet, Ryan Farid, Kirsten M. Edwards, Yeliz Boglev, Rodney B. Luwor, Andrew Jarnicki, David Horst, Alex Boussioutas, Joan K. Heath, Oliver M. Sieber, Irina Pleines, Benjamin T. Kile, Andrew Nash, Florian R. Greten, Brent S. McKenzie, Matthias Ernst. Interleukin-11 Is the Dominant IL-6 Family Cytokine during Gastrointestinal Tumorigenesis and Can Be Targeted Therapeutically. Cancer Cell 2013; 24(2): 257 doi: 10.1016/j.ccr.2013.06.017
|
71 |
Hyung Gyun Kim, Yong Pil Hwang, Eun Hee Han, Jae Ho Choi, Kwang-il Kwon, Young Chul Chung, Myung Ho Jeong, Tae Cheon Jeong, Wonku Kang, Hye Gwang Jeong. The coffee diterpene kahweol inhibits metastasis by modulating expressions of MMPs and VEGF via STAT3 inactivation. Food Chemistry 2012; 133(4): 1521 doi: 10.1016/j.foodchem.2012.02.043
|
72 |
Yosuke Ashizawa, Satoshi Kuboki, Hiroyuki Nojima, Hideyuki Yoshitomi, Katsunori Furukawa, Tsukasa Takayashiki, Shigetsugu Takano, Masaru Miyazaki, Masayuki Ohtsuka. OLFM4 Enhances STAT3 Activation and Promotes Tumor Progression by Inhibiting GRIM19 Expression in Human Hepatocellular Carcinoma. Hepatology Communications 2019; 3(7): 954 doi: 10.1002/hep4.1361
|
73 |
Rodrigo Santa Cruz Guindalini, Maria Cecília Mathias Machado, Bernardo Garicochea. Monitoring Survivin Expression in Cancer: Implications for Prognosis and Therapy. Molecular Diagnosis & Therapy 2013; 17(6): 331 doi: 10.1007/s40291-013-0048-1
|
74 |
Yujuan Chen, Jing Wang, Xiaodong Wang, Xuejuan Liu, Hongjiang Li, Qing Lv, Jingqiang Zhu, Bing Wei, Ying Tang. STAT3, a Poor Survival Predicator, Is Associated with Lymph Node Metastasis from Breast Cancer. Journal of Breast Cancer 2013; 16(1): 40 doi: 10.4048/jbc.2013.16.1.40
|
75 |
Hongwu Zhu, Xiong Chen, Bin Chen, Bei Chen, Jianyong Fan, Weibing Song, Ziying Xie, Dan Jiang, Qiuqiong Li, Meihua Zhou, Dayong Sun, Yagang Zhao. Activating transcription factor 4 mediates a multidrug resistance phenotype of esophageal squamous cell carcinoma cells through transactivation of STAT3 expression. Cancer Letters 2014; 354(1): 142 doi: 10.1016/j.canlet.2014.07.044
|
76 |
Amanda J. Monahan, Michelle Starz-Gaiano. Socs36E attenuates STAT signaling to optimize motile cell specification in the Drosophila ovary. Developmental Biology 2013; 379(2): 152 doi: 10.1016/j.ydbio.2013.03.022
|
77 |
Martin Chevrier, Diwakar Bobbala, Alberto Villalobos-Hernandez, Md Gulam Musawwir Khan, Sheela Ramanathan, Caroline Saucier, Gerardo Ferbeyre, Sameh Geha, Subburaj Ilangumaran. Expression of SOCS1 and the downstream targets of its putative tumor suppressor functions in prostate cancer. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3141-8
|